BREAKING NEWS

BeyondSpring announces submission of New Drug Application (NDA) to U.S. FDA and China NMPA for Plinabulin and G-CSF combination for the prevention of chemotherapy-induced neutropenia (CIN).
Read more

Collaborations

COLLABORATIONS

BeyondSpring leverages its relationships with the broader research community to strengthen its oncology platform and product development strategy. These research collaborators are crucial to the company’s product pipeline growth and continue to offer cost-effective expertise for the company. BeyondSpring anticipates continuing to develop both its R&D collaborations and its business development collaborations to drive the growth of its business.

COLLABORATIONS

Our relationships with the broader research community strengthen our entire oncology platform and product development strategy. These partnerships are key to our product pipeline growth and continue to offer cost-effective expertise.

MASS General Hospital
University of Basel
University of Basel